IL-22 is essential for lung epithelial repair following influenza infection.

Influenza infection is widespread in the United States and the world. Despite low mortality rates due to infection, morbidity is common and little is known about the molecular events involved in recovery. Influenza infection results in persistent distal lung remodeling, and the mechanism(s) involved are poorly understood. Recently IL-22 has been found to mediate epithelial repair. We propose that IL-22 is critical for recovery of normal lung function and architecture after influenza infection. Wild-type and IL-22(-/-) mice were infected with influenza A PR8/34 H1N1 and were followed up for up to 21 days post infection. IL-22 receptor was localized to the airway epithelium in naive mice but was expressed at the sites of parenchymal lung remodeling induced by influenza infection. IL-22(-/-) mice displayed exacerbated lung injury compared with wild-type mice, which correlated with decreased lung function 21 days post infection. Epithelial metaplasia was observed in wild-type mice but was not evident in IL-22(-/-) animals that were characterized with an increased fibrotic phenotype. Gene expression analysis revealed aberrant expression of epithelial genes involved in repair processes, among changes in several other biological processes. These data indicate that IL-22 is required for normal lung repair after influenza infection. IL-22 represents a novel pathway involved in interstitial lung disease.

[1]  D. Artis,et al.  Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung. , 2012, Current opinion in immunology.

[2]  K. Sayama,et al.  IFN-α enhances IL-22 receptor expression in keratinocytes: a possible role in the development of psoriasis. , 2012, The Journal of investigative dermatology.

[3]  T. Oury,et al.  γδ T cells attenuate bleomycin-induced fibrosis through the production of CXCL10. , 2011, The American journal of pathology.

[4]  A. Murphy,et al.  Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. , 2008, Immunity.

[5]  Tomoyuki N. Tanaka,et al.  Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection , 2012, Modern Pathology.

[6]  A. Ferruelo,et al.  Lung histopathological findings in fatal pandemic influenza A (H1N1). , 2012, Medicina intensiva.

[7]  H. Sui,et al.  Pneumonia in novel swine-origin influenza A (H1N1) virus infection: High-resolution CT findings , 2010, European Journal of Radiology.

[8]  Purvesh Khatri,et al.  Onto-Tools: new additions and improvements in 2006 , 2007, Nucleic Acids Res..

[9]  W. Ouyang,et al.  IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection , 2012, Mucosal Immunology.

[10]  A. Gurney,et al.  IL-22 Inhibits Epidermal Differentiation and Induces Proinflammatory Gene Expression and Migration of Human Keratinocytes1 , 2005, The Journal of Immunology.

[11]  R. Xavier,et al.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. , 2008, The Journal of clinical investigation.

[12]  R. Sun,et al.  Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation , 2004, Hepatology.

[13]  J. Alcorn,et al.  Influenza induces endoplasmic reticulum stress, caspase-12-dependent apoptosis, and c-Jun N-terminal kinase-mediated transforming growth factor-β release in lung epithelial cells. , 2012, American journal of respiratory cell and molecular biology.

[14]  R. Sabat,et al.  Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection. , 2010, Cytokine & growth factor reviews.

[15]  N. Kaminski,et al.  Time-Dependent Airway Epithelial and Inflammatory Cell Responses Induced by Influenza Virus A/PR/8/34 in C57BL/6 Mice , 2007, Toxicologic pathology.

[16]  M. I. Ramirez,et al.  The α-Isoform of Caveolin-1 Is a Marker of Vasculogenesis in Early Lung Development , 2002 .

[17]  B. Becher,et al.  IL-22 Is Produced by Innate Lymphoid Cells and Limits Inflammation in Allergic Airway Disease , 2011, PloS one.

[18]  Anand Kumar,et al.  H1N1: viral pneumonia as a cause of acute respiratory distress syndrome , 2011, Current opinion in critical care.

[19]  R. Le Goffic,et al.  Infection with influenza virus induces IL-33 in murine lungs. , 2011, American journal of respiratory cell and molecular biology.

[20]  B. Lambrecht,et al.  Sustained desensitization to bacterial Toll-like receptor ligands after resolutionof respiratory influenza infection , 2008, The Journal of experimental medicine.

[21]  G. Warr,et al.  Alveolitis induced by influenza virus. , 1983, The American review of respiratory disease.

[22]  H. Volk,et al.  IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not , 2009, Journal of Molecular Medicine.

[23]  J. Miyazaki,et al.  High Expression of IL-22 Suppresses Antigen-Induced Immune Responses and Eosinophilic Airway Inflammation via an IL-10–Associated Mechanism , 2011, The Journal of Immunology.

[24]  T. Braciale.  Immunologic recognition of influenza virus-infected cells. I. Generation of a virus-strain specific and a cross-reactive subpopulation of cytotoxic T cells in the response to type A influenza viruses of different subtypes. , 1977, Cellular immunology.

[25]  D. Bassett,et al.  Influenza virus infection, ozone exposure, and fibrogenesis. , 1990, The American review of respiratory disease.

[26]  J. Alcorn,et al.  Critical Role of IL-17RA in Immunopathology of Influenza Infection , 2009, The Journal of Immunology.

[27]  Oliver Eickelberg,et al.  Inhibition and role of let-7d in idiopathic pulmonary fibrosis. , 2010, American journal of respiratory and critical care medicine.

[28]  Anthony S Fauci,et al.  Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. , 2008, The Journal of infectious diseases.

[29]  N. Kaminski,et al.  Molecular staging of epithelial maturation using secretory cell-specific genes as markers. , 2009, American journal of respiratory cell and molecular biology.

[30]  K. Herrmann,et al.  IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[31]  T. Strutt,et al.  Tc17, a Unique Subset of CD8 T Cells That Can Protect against Lethal Influenza Challenge1 , 2009, The Journal of Immunology.

[32]  Yusuke Yamamoto,et al.  Distal Airway Stem Cells Yield Alveoli In Vitro and during Lung Regeneration following H1N1 Influenza Infection , 2011, Cell.

[33]  D. Topham,et al.  Interleukin-22 (IL-22) Production by Pulmonary Natural Killer Cells and the Potential Role of IL-22 during Primary Influenza Virus Infection , 2010, Journal of Virology.

[34]  J. Pfeilschifter,et al.  Protective properties of inhaled IL-22 in a model of ventilator-induced lung injury. , 2011, American journal of respiratory cell and molecular biology.

[35]  P. Khatri,et al.  A systems biology approach for pathway level analysis. , 2007, Genome research.

[36]  J. Alcorn,et al.  Strain-dependent activation of NF-kappaB in the airway epithelium and its role in allergic airway inflammation. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[37]  M. I. Ramirez,et al.  The alpha-isoform of caveolin-1 is a marker of vasculogenesis in early lung development. , 2002, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  James Lyons-Weiler,et al.  caGEDA: a web application for the integrated analysis of global gene expression patterns in cancer , 2004, Applied bioinformatics.

[39]  A. Gurney,et al.  Acinar cells of the pancreas are a target of interleukin-22. , 2001, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[40]  Thorsten Wolff,et al.  Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells , 2006, Cellular microbiology.

[41]  D. Artis,et al.  Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A , 2010, The Journal of experimental medicine.

[42]  N. King,et al.  IL‐22 and non‐ELR‐CXC chemokine expression in chronic hepatitis B virus‐infected liver , 2012, Immunology and cell biology.

[43]  M. Neurath,et al.  STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing , 2009, The Journal of experimental medicine.

[44]  W. Born,et al.  γδ T cells protect against lung fibrosis via IL-22 , 2010, The Journal of experimental medicine.

[45]  V. Chow,et al.  MCP-1 antibody treatment enhances damage and impedes repair of the alveolar epithelium in influenza pneumonitis. , 2010, American journal of respiratory cell and molecular biology.

[46]  L. Fouser,et al.  Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides , 2006, The Journal of experimental medicine.

[47]  H. Rosen,et al.  Interleukin (IL)-17/IL-22-Producing T cells Enriched Within the Liver of Patients with Chronic Hepatitis C Viral (HCV) Infection , 2012, Digestive Diseases and Sciences.

[48]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[49]  M. Yamashita,et al.  Serial Histopathological Examination of the Lungs of Mice Infected with Influenza A Virus PR8 Strain , 2011, PloS one.

[50]  J. Renauld,et al.  Interleukin-22 Is Produced by Invariant Natural Killer T Lymphocytes during Influenza A Virus Infection , 2012, The Journal of Biological Chemistry.

[51]  M. Zompatori,et al.  Post-ARDS pulmonary fibrosis in patients with H1N1 pneumonia: role of follow-up CT , 2011, La radiologia medica.

[52]  M. Fei,et al.  IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia , 2008, Nature Medicine.

[53]  T. Ross,et al.  Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA. , 2011, PLoS currents.

[54]  I. Julkunen,et al.  IFNs activate toll-like receptor gene expression in viral infections , 2001, Genes and Immunity.

[55]  David Artis,et al.  Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus , 2011, Nature Immunology.

[56]  G. Jakab.  Sequential virus infections, bacterial superinfections, and fibrogenesis. , 1990, The American review of respiratory disease.

[57]  F. Morel,et al.  A role for T cell‐derived interleukin 22 in psoriatic skin inflammation , 2007, Clinical and experimental immunology.

[58]  A. Shahangian,et al.  Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. , 2009, The Journal of clinical investigation.

[59]  R. Sun,et al.  Antiapoptotic Activity of Autocrine Interleukin-22 and Therapeutic Effects of Interleukin-22-Small Interfering RNA on Human Lung Cancer Xenografts , 2008, Clinical Cancer Research.

[60]  J. Alcorn,et al.  Influenza A Inhibits Th17-Mediated Host Defense against Bacterial Pneumonia in Mice , 2011, The Journal of Immunology.

[61]  R. de Waal Malefyt,et al.  Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. , 2004, International immunopharmacology.